J
Julie R. Perlin
Researcher at Howard Hughes Medical Institute
Publications - 25
Citations - 2869
Julie R. Perlin is an academic researcher from Howard Hughes Medical Institute. The author has contributed to research in topics: Haematopoiesis & Cellular differentiation. The author has an hindex of 16, co-authored 23 publications receiving 2483 citations. Previous affiliations of Julie R. Perlin include Stanford University & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Human PAD4 regulates histone arginine methylation levels via demethylimination.
Yanming Wang,Joanna Wysocka,Joyce Sayegh,Youngho Lee,Julie R. Perlin,Lauriebeth Leonelli,Lakshmi S. Sonbuchner,Charles H. McDonald,Richard G. Cook,Yali Dou,Robert G. Roeder,Steven Clarke,Michael R. Stallcup,C. David Allis,Scott A. Coonrod +14 more
TL;DR: It is demonstrated that human peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine, and that PAD4 activity is linked with the transcriptional regulation of estrogen-responsive genes in MCF-7 cells.
Journal ArticleDOI
Asymmetric Inheritance of Mother Versus Daughter Centrosome in Stem Cell Division
TL;DR: It is shown that developmentally programmed asymmetric behavior and inheritance of mother and daughter centrosomes underlies the stereotyped spindle orientation and asymmetric outcome of stem cell divisions in the Drosophila male germ line.
Journal ArticleDOI
A G Protein-Coupled Receptor is Essential for Schwann Cells to Initiate Myelination
Kelly R. Monk,Stephen G. Naylor,Thomas D. Glenn,Sara Mercurio,Julie R. Perlin,Claudia X. Dominguez,Cecilia B. Moens,William S. Talbot +7 more
TL;DR: It is proposed that Gpr126 drives the differentiation of promyelinating Schwann cells by elevating cAMP levels, thereby triggering Oct6 expression and myelination in zebrafish.
Journal ArticleDOI
Tumor-Derived Extracellular Vesicles Breach the Intact Blood–Brain Barrier via Transcytosis
Golnaz Morad,Golnaz Morad,Christopher V. Carman,Elliott J. Hagedorn,Elliott J. Hagedorn,Julie R. Perlin,Julie R. Perlin,Leonard I. Zon,Leonard I. Zon,Nur Mustafaoglu,Tae-Eun Park,Tae-Eun Park,Donald E. Ingber,Donald E. Ingber,Donald E. Ingber,Cassandra C. Daisy,Marsha A. Moses,Marsha A. Moses +17 more
TL;DR: These findings identify previously unknown mechanisms by which tumor-derived EVs breach an intact BBB during the course of brain metastasis and can be leveraged to guide and inform the development of drug delivery approaches to deliver therapeutic cargoes across the BBB for treatment of a variety of brain diseases.
Journal ArticleDOI
Dynamic alterations of specific histone modifications during early murine development
Olga F. Sarmento,Laura Digilio,Yanming Wang,Julie R. Perlin,John C. Herr,C. David Allis,Scott A. Coonrod,Scott A. Coonrod +7 more
TL;DR: Changes in global levels of a series of histone tail modifications were studied during oocyte maturation and pre-implantation mouse development using indirect immunofluorescence and scanning confocal microscopy to provide data demonstrating that treatment of cellular histones with peptidylarginine deiminase (PAD) results in loss of staining for the histone H4 arginine 3 methyl mark, suggesting that PADs can reverse histone arginines methyl modifications.